コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 l basis for a putative role of sbGnRH as the gonadotropin-releasing hormone.
2 gonadotropes, and this effect is enhanced by gonadotropin-releasing hormone.
3 to provide an episodic, excitatory drive to gonadotropin-releasing hormone 1 (GnRH) neurons, the syn
6 thalamic neurons that synthesize and release gonadotropin-releasing hormone 1 (GnRH1), but the precis
8 cystokinin (CCK) in the developing olfactory-gonadotropin-releasing hormone-1 (GnRH-1) neuroendocrine
10 asic ovarian sex hormone fluctuation using a gonadotropin-releasing hormone agonist (GnRHa) and evalu
11 rted previously that after 1-year follow up, gonadotropin-releasing hormone agonist (GnRHa) did not p
12 by surgical castration and those who receive gonadotropin-releasing hormone agonist (GnRHa) therapy.
13 nditions: ovarian suppression induced by the gonadotropin-releasing hormone agonist leuprolide acetat
15 umulation increased after treatment with the gonadotropin-releasing hormone agonist leuprolide, which
17 over study, 12 healthy, young males received gonadotropin-releasing hormone agonist treatment 1 month
18 ceptive use or progesterone treatment, prior gonadotropin-releasing hormone agonist treatment, and pr
19 nditions: ovarian suppression induced by the gonadotropin-releasing hormone agonist, leuprolide aceta
20 al women, or premenopausal women receiving a gonadotropin-releasing hormone agonist, with estrogen re
21 nmetastatic disease, intervention group with gonadotropin-releasing hormone agonist-based ADT, contro
25 production was achieved with the use of the gonadotropin-releasing-hormone agonist triptorelin, ooph
27 herapies (OR, 4.04 [95% CI, 1.88-8.69]), and gonadotropin-releasing hormone agonists (OR, 1.93 [95% C
28 androgen deprivation therapy in the form of gonadotropin-releasing hormone agonists and newer antago
31 y a combined androgen blockade consisting of gonadotropin-releasing hormone agonists with oral antian
32 er treatments such as surgical oophorectomy, gonadotropin-releasing hormone agonists, chemotherapy-in
33 rized into 1 of 6 mutually exclusive groups: gonadotropin-releasing hormone agonists, oral antiandrog
34 ess of depot leuprolide acetate, a synthetic gonadotropin-releasing hormone analog (GnRH-a), for prot
35 of glucocorticoid replacement, 19.2%; and of gonadotropin-releasing hormone analog therapy, 34.2%.
38 rel-releasing intrauterine system (LNG-IUD), gonadotropin-releasing hormone analogues (GnRHa; nafarel
40 n suppression (castration via orchiectomy or gonadotropin-releasing hormone analogues) suppresses cir
42 399R) had attenuated secretion of endogenous gonadotropin-releasing hormone and a left-shifted dose-r
43 siveness to both exogenous gonadotropins and gonadotropin-releasing hormone and had normal levels of
44 ikely to be mediated by reduced secretion of gonadotropin-releasing hormone and our results support t
46 onsiveness to the endogenous natural ligand, gonadotropin releasing hormone, and an agonist that is s
48 o the antral stage in both immature mice and gonadotropin releasing hormone antagonist-treated adult
50 (ii) a single subcutaneous injection of the gonadotropin-releasing hormone antagonist (GnRH-A), acyl
51 le-stimulating hormone and administration of gonadotropin-releasing hormone antagonist to prevent pre
52 of short-term castration (1 month) using the gonadotropin-releasing hormone antagonist, Acyline, vers
53 been found for other classes of drugs (e.g., gonadotropin-releasing hormone antagonists, neurokinin r
54 tostatin agonists, urotensin II antagonists, gonadotropin-releasing hormone antagonists, neurotensin
55 e and a left-shifted dose-response curve for gonadotropin-releasing hormone as compared with six pati
56 h, and adrenal maturation, is initiated when gonadotropin-releasing hormone begins to be secreted by
57 levels are increased somewhat by exposure to gonadotropin-releasing hormone but are not necessarily l
59 17beta-estradiol (E2) regulating release of gonadotropin releasing hormone (GnRH) and luteinizing ho
60 tress index, CSI), women self administered a gonadotropin releasing hormone (GnRH) antagonist for 16
62 ntrolled in part by the pulsatile release of gonadotropin releasing hormone (GnRH) from the hypothala
64 stone deacetylases (HDACs) in the control of gonadotropin releasing hormone (GnRH) neuronal developme
65 odulate the central driver of fertility: the gonadotropin releasing hormone (GnRH) neuronal system.
66 gy balance and season, time the awakening of gonadotropin releasing hormone (GnRH) neurons at the ons
67 onadotropic hypogonadism to study effects of gonadotropin releasing hormone (GnRH) neurons on neurona
68 regions contain cell bodies and/or fibers of gonadotropin releasing hormone (GnRH) neurons, suggestin
72 acetate, a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH or LHRH), is the ac
74 a potent and very long acting antagonist of gonadotropin-releasing hormone (GnRH) after subcutaneous
75 mone but apparently normal responsiveness to gonadotropin-releasing hormone (GnRH) agonist and antago
77 bserved by MIS, which enhances the effect of gonadotropin-releasing hormone (GnRH) agonist on the FSH
79 bjected to 26 ART treatment cycles receiving gonadotropin-releasing hormone (GnRH) agonists and recom
84 n were on antiandrogens (AA), 26,959 were on gonadotropin-releasing hormone (GnRH) agonists, and 3,74
85 ective randomized trial evaluated the use of gonadotropin-releasing hormone (GnRH) analog triptorelin
90 ted with oocyte meiosis, TGF-beta signaling, gonadotropin-releasing hormone (GnRH) and epidermal grow
92 and controls the synthesis and/or release of gonadotropin-releasing hormone (GnRH) and gonadotropins.
93 ons are thought to regulate the secretion of gonadotropin-releasing hormone (GnRH) and thus coordinat
97 amining the distribution of cells containing gonadotropin-releasing hormone (GnRH) as well as estroge
98 male rat preoptic area (POA), containing the gonadotropin-releasing hormone (GnRH) cell bodies, treat
99 ypothalamic-pituitary-ovarian axis, in which gonadotropin-releasing hormone (GnRH) controls the relea
101 othalamic amenorrhea is a reversible form of gonadotropin-releasing hormone (GnRH) deficiency commonl
107 been established that episodic secretion of gonadotropin-releasing hormone (GnRH) from the hypothala
108 Individuals with an inherited deficiency in gonadotropin-releasing hormone (GnRH) have impaired sexu
109 action on puberty by stimulating release of gonadotropin-releasing hormone (GnRH) in the hypothalamu
110 levated levels of transcripts for the salmon gonadotropin-releasing hormone (GnRH) in the male telenc
112 that FOXO1 repressed basal transcription and gonadotropin-releasing hormone (GnRH) induction of both
113 amic median eminence (ME) where they release gonadotropin-releasing hormone (GnRH) into a specialized
119 propriate tissue-specific gene expression of gonadotropin-releasing hormone (GnRH) is critical for pu
123 n of ERK1/2 by the hypothalamic neuropeptide gonadotropin-releasing hormone (GnRH) is relatively sust
137 (RFRP-3) neurons have been shown to inhibit gonadotropin-releasing hormone (GnRH) neuronal activity
138 a profound influence on the activity of the gonadotropin-releasing hormone (GnRH) neuronal network c
150 sspeptin neurons act cooperatively to excite gonadotropin-releasing hormone (GnRH) neurons during pos
153 al axis is dependent on correct migration of gonadotropin-releasing hormone (GnRH) neurons from the n
154 oductive functioning in mammals depends upon gonadotropin-releasing hormone (GnRH) neurons generating
155 in mice for controlling the activity of the gonadotropin-releasing hormone (GnRH) neurons in vivo to
157 ut from the suprachiasmatic nucleus (SCN) to gonadotropin-releasing hormone (GnRH) neurons is critica
163 n, rostral projections from the AVPV contact gonadotropin-releasing hormone (GnRH) neurons surroundin
164 onstructions and electrophysiology, that the gonadotropin-releasing hormone (GnRH) neurons that contr
165 rculating estradiol on proestrus to activate gonadotropin-releasing hormone (GnRH) neurons that, in t
166 estradiol (E2) regulates the activity of the gonadotropin-releasing hormone (GnRH) neurons through bo
167 nisms through which estradiol (E2) regulates gonadotropin-releasing hormone (GnRH) neurons to control
168 s how nerve terminal Ca(2+) is controlled in gonadotropin-releasing hormone (GnRH) neurons via action
169 peptin regulates reproduction by stimulating gonadotropin-releasing hormone (GnRH) neurons via the ki
171 mice lacking necdin have reduced numbers of gonadotropin-releasing hormone (GnRH) neurons, but the m
172 eactive fibres also abut the preoptic-septal gonadotropin-releasing hormone (GnRH) neurons, suggestin
173 siological processes including activation of gonadotropin-releasing hormone (GnRH) neurons, the neura
174 ne hormone secretion, especially that of the gonadotropin-releasing hormone (GnRH) neurons, via neura
175 arcuate nucleus (Arc) provide tonic drive to gonadotropin-releasing hormone (GnRH) neurons, which in
184 yclicity, including long-acting analogues of gonadotropin-releasing hormone (GnRH) or oestradiol (adm
185 Most cells are immunoreactive for either gonadotropin-releasing hormone (GnRH) or RF-amide-like p
188 ty of kisspeptin-10 to elicit the release of gonadotropin-releasing hormone (GnRH) precociously, and
189 genes are expressed under the control of the gonadotropin-releasing hormone (GnRH) promoter has made
195 o and caused cell death in cells bearing the gonadotropin-releasing hormone (GnRH) receptor, we could
196 ion as a measure of information transfer via gonadotropin-releasing hormone (GnRH) receptors (GnRHR)
198 have specialized adaptations associated with gonadotropin-releasing hormone (GnRH) regulation to opti
204 of reproduction by brain-secreted pulses of gonadotropin-releasing hormone (GnRH) represents a longs
206 otropic hypogonadism (IHH) due to defects of gonadotropin-releasing hormone (GnRH) secretion and/or a
210 in the regulation of pubertal and adulthood gonadotropin-releasing hormone (GnRH) secretion, and mut
215 ic hypogonadism had a measurable response to gonadotropin-releasing hormone (GnRH) stimulation, sugge
217 lmann syndrome is an inherited deficiency of gonadotropin-releasing hormone (GnRH) that is characteri
218 sulting in a massive release of hypothalamic gonadotropin-releasing hormone (GnRH) that peaks within
219 rmal puberty promotes the central release of gonadotropin-releasing hormone (GnRH) that, in turn, lea
220 revealed that IKK-beta and NF-kappaB inhibit gonadotropin-releasing hormone (GnRH) to mediate ageing-
222 itary gonadotropin hormones are regulated by gonadotropin-releasing hormone (GnRH) via MAPK signaling
223 duce ciliated neurons that express genes for gonadotropin-releasing hormone (GnRH), a G-protein-coupl
224 ) designed to express an antibody that binds gonadotropin-releasing hormone (GnRH), a master regulato
225 and negative modulators drives secretion of gonadotropin-releasing hormone (GnRH), a neuropeptide th
226 (MCH), thyrotropin-releasing hormone (TRH), gonadotropin-releasing hormone (GnRH), and kisspeptin.
227 brain controls fertility through release of gonadotropin-releasing hormone (GnRH), but the mechanism
228 he FSHbeta subunit is primarily regulated by gonadotropin-releasing hormone (GnRH), gonadal steroids,
229 under the control of pulsatile hypothalamic gonadotropin-releasing hormone (GnRH), is essential for
231 pite of the fact that hypothalamic levels of gonadotropin-releasing hormone (GnRH), pituitary release
232 sprouting in hypothalamic neurons secreting gonadotropin-releasing hormone (GnRH), the neuropeptide
233 blished that hypothalamic neurons, including gonadotropin-releasing hormone (GnRH), VP, OT, beta-endo
235 ndent upon the appropriate neurosecretion of gonadotropin-releasing hormone (GnRH), yet the endogenou
238 lamic-pituitary-gonadal axis is dependent on gonadotropin-releasing hormone (GNRH)-stimulated synthes
249 rmone-releasing hormone (LHRH, also known as gonadotropin-releasing hormone [GnRH]), a key neurohormo
250 e reproduction requires pulsatile release of gonadotropin-releasing hormone (GnRH1) from the hypothal
251 In mammals, the receptor of the neuropeptide gonadotropin-releasing hormone (GnRHR) is unique among t
252 basis of selectivity of naturally occurring gonadotropin-releasing hormones (GnRHs) from different s
254 r fibers were observed in close proximity to gonadotropin-releasing hormone-I, dopamine, beta-endorph
255 ing hormone-I, dopamine, beta-endorphin, and gonadotropin-releasing hormone-II neurons in the preopti
256 n-releasing hormone and had normal levels of gonadotropin-releasing hormone in the hypothalamus.
257 a neuropeptide homologous to the vertebrate gonadotropin-releasing hormone, is downregulated as work
258 ty and infertility as a result of defects in gonadotropin-releasing hormone neuron development or fun
259 st gonadotropin responses, suggesting normal gonadotropin-releasing hormone neuronal and gonadotrope
261 se neurons also precede the emergence of the gonadotropin-releasing hormone neurons and ensheathing g
262 lamic nucleus and send axonal projections to gonadotropin-releasing hormone neurons and regulate repr
264 Notably, TRPC1 suppressed the migration of gonadotropin-releasing hormone neurons without affecting
265 Z formed appositions with orexin neurons and gonadotropin-releasing hormone neurons, two cell populat
267 ed hypothalamic cells and immortalized GnRH (gonadotropin-releasing hormone) neurons (GT1-7 cells) tr
268 g hormone, growth hormone-releasing hormone, gonadotropin-releasing hormone, oxytocin, somatostatin,
269 g that this receptor is essential for normal gonadotropin-releasing hormone physiology and for pubert
270 cant relation between the number of doses of gonadotropin-releasing hormone received during the 12 mo
272 ere designed and synthesized as potent human gonadotropin releasing hormone receptor antagonists.
274 in-conjugated gold nanorods (gGNRs) promotes gonadotropin releasing hormone receptor-mediated interna
275 eptide agonists and antagonists of the human gonadotropin-releasing hormone receptor (GnRH-R) are wid
276 eurons (GT1-7 cells), agonist binding to the gonadotropin-releasing hormone receptor (GnRH-R) causes
279 r reproductive traits, growth hormone (GHR), gonadotropin-releasing hormone receptor (GNRHR) and neur
282 on in pedigree 1 and a compound heterozygous gonadotropin-releasing hormone receptor (GNRHR) mutation
283 icipate in partitioning mutant conformers of gonadotropin-releasing hormone receptor (GnRHR), a G pro
284 mines bearing a butyric acid as potent human gonadotropin-releasing hormone receptor (hGnRH-R) antago
285 he C-terminal domains of either GluR1 or the gonadotropin-releasing hormone receptor permits efficien
287 regulation (reduced pituitary sensitivity to gonadotropin-releasing hormone), reduced conception rate
288 oter activity, highlighting a role of SET in gonadotropin-releasing hormone regulation of gene expres
289 from the Kiss1 promoter disrupted pulsatile gonadotropin-releasing hormone release, delayed puberty
292 ns, suggesting sensitization of the NKB-NK3R-gonadotropin-releasing hormone signaling pathway under m
294 lular: oxytocin, vasopressin; parvicellular: gonadotropin-releasing hormone, somatostatin, thyrotropi
295 these two factors is essential in mediating gonadotropin-releasing hormone stimulation of LHbeta pro
296 androgen receptors, and by the hypothalamic gonadotropin-releasing hormone through activation of PKA
297 olic, and other factors control secretion of gonadotropin-releasing hormone to determine initiation o
298 uires the pulsatile, coordinated delivery of gonadotropin-releasing hormone to the pituitary and the
300 uctive function requires timely secretion of gonadotropin-releasing hormone, which is controlled by a
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。